Book Appointment Now
Our News
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases
Multi-program collaboration leveraging QurCan’s TERP™ polymer-lipid nanoparticle delivery platform Lilly...
Read MoreQurCan Therapeutics (AKA Nanology Labs) Secures $3 Million in Oversubscribed Seed Round
QurCan Therapeutics (AKA Nanology Labs) Secures $3 Million in Oversubscribed...
Read More